Fiscal Year 2016: Vaccine Safety Cooperative Agreements; 2 awards each for $250,000 for FY2015
Vaccine Confidence 1 award for $250,000 for FY2016.
Fiscal Year 2017: $750,000.
Fiscal Year 2018: 750,000.
The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
|Recipient||Amount||Start Date||End Date|
|Kaiser Foundation Hospitals||$ 338,425||   ||2017-07-01||2019-06-30|
|Emory University||$ 0||   ||2016-07-01||2019-03-31|
|Children's Hospital Medical Center||$ 250,000||   ||2017-07-01||2018-12-31|
|Rockefeller University, The||$ 161,575||   ||2017-07-01||2018-06-30|
|Emory University||$ 250,000||   ||2016-07-01||2018-06-30|
|Kaiser Foundation Hospitals||-$ 16,475||   ||2015-08-01||2017-01-30|
|Kaiser Foundation Hospitals||-$ 3,214||   ||2015-08-01||2016-12-31|
|Kaiser Foundation Hospitals||$ 249,393||   ||2015-08-01||2016-07-31|
|Kaiser Foundation Hospitals||$ 249,988||   ||2015-08-01||2016-07-31|
|$ 0||   |
Fiscal Year 2016: Vaccine Confidence 1 award for $250,000 for FY2016. Fiscal Year 2017: Awardee: Kaiser Foundation Hospitals Project Award: $338,425 Description: This project focuses on adversomics. It aims to identify inherited, immunologic, and clinical factors that may predict the occurrence of febrile seizures after measles vaccination. Awardee: Cincinnati Children's Hospital Medical Center Project Award: $250,000 Description: This project focuses on maternal immunization safety. It aims to validate the Global Alignment of Immunization Safety Assessment in pregnancy (GAIA) maternal and neonatal outcome definitions to standardize the evaluation of the safety of vaccines. Awardee: The Rockefeller University Project Award: $161,575 Description: This project focuses on precision medicine. It aims to analyze the genetic determinants of the immune response following yellow fever vaccination among individuals who experience serious adverse events. Fiscal Year 2018: unknown at this time.
Uses and Use Restrictions
The assistance can be applied to improving vaccine safety knowledge, improving the monitoring of adverse events following immunization, including vaccines used by adults over 65 years old.
Examples of applicability are predicting the safety profile of new vaccines during the early development stage, developing or modifying existing vaccines to improve their safety, conducting applied research that will have a direct impact on the current vaccine safety monitoring system, conducting research that will improve the safety profile of currently marketed vaccines, conducting research that will improve the understanding of the safety profile of immunizations that are or will be recommended for adults over 65 years old.
There is approximately $500,000 available.
Funds are restricted from being used for the following: alterations or renovations; construction; fund-raising activities; job training; political education and lobbying; vocational rehabilitation.
There is approximately $500,000 available for up to 2 cooperative agreements.
Public (including city, county, regional, and State government) organizations and private nonprofit entities.
Improving vaccine safety for adults.
A nonprofit private entity must provide evidence of its nonprofit status. Allowability of costs charged to the cooperative agreement will be determined in accordance with the following Cost Principles: OMB Circular No. A-21 for educational institutions, OMB Circular No. A-122 for nonprofit organizations. Faith based organizations are eligible to apply. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. To apply, access the announcement through www.grants.gov. Enter the CFDA# and follow the website instructions. Applications submitted after the deadline will not be accepted for review. The submission deadline will not be extended. Applications which do not conform to the requirements of the grant announcement will not be accepted for review. Applications may only be submitted electronically via www.grants.gov. Any applications submitted via any other means of electronic communication, including facsimile or electronic mail, will not be accepted for review.
Applications will be screened upon receipt. Those that are judged to be ineligible will not be reviewed. Accepted applications will be reviewed for technical merit in accordance with PHS policies. Applications will be evaluated by a technical review panel composed of experts. Final funding decisions will be determined by the NVPO Office Director; taken into consideration are the recommendations of the review panel; program needs, stated preferences; geographic location. All applicants are notified in writing of actions taken on their applications. A Notice of Award is issued for those applications that are approved and funded.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Section 1702(a) [42 U.S.C. 300u-1(a)] and Section 1703(a) and (c) [42 U.S.C. 300u-2(a) and (c)] of the Public Health Service Act, as amended.
Range of Approval/Disapproval Time
> 180 Days. from 6 to 9 months.
Formula and Matching Requirements
This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.
Length and Time Phasing of Assistance
Cooperative Agreements may not exceed 2 years (subject to the availability of funds). Payment will be made either on a monthly cash request basis or under Electronic Transfer System. Necessary instructions for the appropriate type of payment will be issued at the time an award is made. Method of awarding/releasing assistance: by letter of credit.
Post Assistance Requirements
Quarterly and Annual Progress Reports must be submitted each year.
A Final Report will be due 90 days after the end of the project period.
Federal Financial Reports (FFR) SF425 are required quarterly, and must be submitted to Payment Management Services 30 days after the end of each calendar quarter.
A revised work plan must be submitted each year to indicate any service and/or partnership revisions.
Quarterly SF425 Federal Financial Reports must be submitted to the Office of Grants Management 30 days after the end of each calendar quarter and an annual FFR 90 days after the end of the budget period/project period end date.
Reports are to be submitted electronically through GrantSolutions.
A final performance report is due 90 days following the end of the project period.
No audits are required for this program.
HHS and the Comptroller General of the United States or any of their authorized representatives shall have the right of access to any books, documents, papers, or other records of a grantee, sub-grantee, contractor, or subcontractor, which are pertinent to the HHS grant, in order to make audits, examinations, excerpts and transcripts. In accordance with 45 CFR, Part 74.53 and 45 CFR, Part 92, grantees are required to maintain grant accounting records 3 years after the end of a project period. If any litigation, claim, negotiation, audit or other action involving the records has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later.
(Cooperative Agreements) FY 16 $250,000; FY 17 est $750,000; and FY 18 Estimate Not Available
Range and Average of Financial Assistance
Estimated Funds Available for Competition $750,000.
Regulations, Guidelines, and Literature
HHS Grants Policy Statement is available online: http://www.ahrq.gov/funding/policies/hhspolicy/index.html HHS Grants Policies and Regulations are available online: http://www.hhs.gov/grants/grants/grants-policies-regulations/
Regional or Local Office
See Regional Agency Offices. Karin Bok, MS, PhD 202-690-1191 Karin.Bok@hhs.gov.
Eric C. West Tower Building Suite 550, 1101 Wootton Parkway, Rockville, Maryland 20852 Email: email@example.com Phone: (240) 453-8822.
Criteria for Selecting Proposals
Please see the current FOA.